3+ day, 18+ hour ago   (293+ words) Sept 10 (Reuters) – Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials of its experimental epilepsy drug ​after rodent findings, sending its shares down more than ‌15% in early trading. • The U....

5+ day, 11+ hour ago   (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns ​about the prospects of similar therapies for the tough-to-treat ‌rare disease. Dyne’s stock led declines…...

5+ day, 20+ hour ago   (257+ words) Sept 8 (Reuters) – Bristol Myers Squibb said on Tuesday its experimental cell therapy showed a high overall response rate in a mid-stage trial, ​in patients with a hard-to-treat form of ‌blood cancer. The study evaluated the therapy, called arlocabtagene autoleucel, or…...

6+ day, 19+ hour ago   (191+ words) Sept 7 (Reuters) – Novo Nordisk said on Monday it had halted two additional trials of its ​experimental cardiovascular drug ziltivekimab, further ‌denting the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes franchise. In July, Novo said ziltivekimab failed…...

1+ week, 4+ hour ago   (440+ words) DHAKA, Sept 6 (Reuters) – Bangladesh’s dengue outbreak is accelerating, with 42,590 people hospitalised and 117 deaths recorded this year, as a sharp September surge strains hospitals and raises fears the mosquito-borne disease could intensify further in the coming weeks. At least four dengue…...

1+ week, 2+ day ago   (464+ words) By Christy Santhosh and Bhanvi Satija Sept 4 (Reuters) – Novartis said on Friday its experimental drug pelacarsen did not cut the risk of major heart attacks and strokes in patients with a genetic risk factor in a late-stage trial, marking a…...

1+ week, 6+ day ago   (461+ words) LONDON, Sept 1 (Reuters) – Swiss drugmaker Novartis said on Tuesday its oral drug remibrutinib outperformed an older treatment in reducing relapses in patients with a form of multiple sclerosis, boosting hopes the medicine could become a blockbuster product. The trial results…...

1+ week, 6+ day ago   (207+ words) Sept 1 (Reuters) – AstraZeneca and China’s Hutchmed said on Tuesday that a late-stage trial of a combination of their ​cancer drugs Tagrisso and Orpathys ‌significantly improved progression-free survival when given early for a type of lung cancer. Cancer therapies make up…...

1+ week, 6+ day ago   (320+ words) Sept 1 (Reuters) – Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late August, after ​three patients died. The halt was implemented on August 24 ‌after Novartis was notified…...

3+ week, 5+ day ago   (228+ words) Aug 18 (Reuters) – The Centers for Disease Control and Prevention on Tuesday reported 15,716 confirmed cases of cyclosporiasis in the United ​States, an increase of 1,821 cases ‌from a week ago. • The CDC said it has received reports of 15,716 confirmed cases of cyclosporiasis…...